Key result
Asymptomatic peripheral arterial disease was associated with significantly worse performance on five cognitive tests compared to healthy controls (P < 0.0001).
Why the study?
Is cognitive function impaired in stroke- and TIA-free patients with asymptomatic peripheral arterial disease compared to healthy controls, and are inflammatory/haemostatic markers associated with this performance?
Case-Control (n=328)
Is cognitive function impaired in stroke- and TIA-free patients with asymptomatic peripheral arterial disease compared to healthy controls, and are inflammatory/haemostatic markers associated with this performance?
p-value: p=< 0.0001
Asymptomatic peripheral arterial disease is associated with cognitive impairment, which is independently predicted by elevated levels of inflammatory and haemostatic markers like CRP and D-dimer.
Supports cognitive assessment in asymptomatic PAD; leaves open causality and intervention effects in prospective studies.
BACKGROUND AND PURPOSE: asymptomatic peripheral arterial disease (APAD), a highly prevalent condition in the general older population, is associated with an increased risk of cerebrovascular events because of co-existing clinical or subclinical cerebral atherosclerosis. The purpose of this study was to investigate whether cognitive function is impaired in stroke- and transient ischaemic attack-free patients with APAD, and whether inflammatory and haemostatic markers are associated independently with neuropsychological performance. METHODS: cognitive performances of 164 well-functioning, community-dwelling patients with APAD were compared with those of 164 age-, gender- and education-matched healthy control subjects on six neuropsychological tests. Levels of C-reactive protein (CRP), D-dimer and fibrinogen were also analysed in all participants. RESULTS: patients with APAD scored significantly worse (P < 0.0001) than control subjects on five cognitive tests assessing domains of verbal working memory, attention, perceptuomotor speed, mental flexibility, visuoconstructive skills and visual memory. Multiple linear regression analyses showed that CRP and D-dimer were significant, independent predictors of poorer performances on four and three cognitive tests, respectively, within patients with APAD. CONCLUSIONS: patients with APAD show cognitive impairment in a range of psychometric tests, and CRP and D-dimer appear to be independent negative predictors of some cognitive performances. These findings suggest the need for screening for APAD among at-risk subjects in order to identify patients to be treated for prevention of functional decline and dementia. They also support the hypothesis that inflammation and hypercoagulability are implicated in the pathophysiology of cognitive dysfunction associated with APAD.
No takes yet. Share an insight, caveat, or question.
Mangiafico et al. (2005) conducted a case-control in Asymptomatic peripheral arterial disease (n=328). Asymptomatic peripheral arterial disease vs. Healthy control subjects was evaluated on Cognitive performances on six neuropsychological tests (p=< 0.0001). Asymptomatic peripheral arterial disease was associated with significantly worse performance on five cognitive tests compared to healthy controls (P < 0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: